These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7591216)

  • 1. Cellular pharmacology of azatoxins (topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and -negative cell lines.
    Eymin B; Solary E; Chevillard S; Dubrez L; Goldwasser F; Duchamp O; Genne P; Leteurtre F; Pommier Y
    Int J Cancer; 1995 Oct; 63(2):268-75. PubMed ID: 7591216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent.
    Solary E; Leteurtre F; Paull KD; Scudiero D; Hamel E; Pommier Y
    Biochem Pharmacol; 1993 Jun; 45(12):2449-56. PubMed ID: 8392342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azatoxin derivatives with potent and selective action on topoisomerase II.
    Leteurtre F; Sackett DL; Madalengoitia J; Kohlhagen G; MacDonald T; Hamel E; Paull KD; Pommier Y
    Biochem Pharmacol; 1995 May; 49(9):1283-90. PubMed ID: 7763310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin.
    Leteurtre F; Madalengoitia J; Orr A; Guzi TJ; Lehnert E; Macdonald T; Pommier Y
    Cancer Res; 1992 Aug; 52(16):4478-83. PubMed ID: 1322792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line.
    Takeda Y; Nishio K; Niitani H; Saijo N
    Int J Cancer; 1994 Apr; 57(2):229-39. PubMed ID: 7908894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin.
    Tomida A; Naito M; Tsuruo T
    Jpn J Cancer Res; 1995 Feb; 86(2):224-32. PubMed ID: 7730148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
    Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
    Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
    Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxins.
    Miller TA; Vachaspati PR; Labroli MA; Thompson CD; Bulman AL; Macdonald TL
    Bioorg Med Chem Lett; 1998 May; 8(9):1065-70. PubMed ID: 9871709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.
    Bal C; Baldeyrou B; Moz F; Lansiaux A; Colson P; Kraus-Berthier L; Léonce S; Pierré A; Boussard MF; Rousseau A; Wierzbicki M; Bailly C
    Biochem Pharmacol; 2004 Nov; 68(10):1911-22. PubMed ID: 15476662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.
    Horichi N; Tapiero H; Sugimoto Y; Bungo M; Nishiyama M; Fourcade A; Lampidis TJ; Kasahara K; Sasaki Y; Takahashi T
    Cancer Res; 1990 Aug; 50(15):4698-701. PubMed ID: 2164445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship for DNA topoisomerase II-induced DNA cleavage by azatoxin analogues.
    Madalengoitia JS; Tepe JJ; Werbovetz KA; Lehnert EK; Macdonald TL
    Bioorg Med Chem; 1997 Sep; 5(9):1807-15. PubMed ID: 9354236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
    Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
    Takeda Y; Nishio K; Sugimoto Y; Kasahara K; Kubo S; Fujiwara Y; Niitani H; Saijo N
    Int J Cancer; 1991 Jul; 48(6):931-7. PubMed ID: 1677641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II.
    Mistry P; Stewart AJ; Dangerfield W; Baker M; Liddle C; Bootle D; Kofler B; Laurie D; Denny WA; Baguley B; Charlton PA
    Anticancer Drugs; 2002 Jan; 13(1):15-28. PubMed ID: 11914637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K; Tsuruo T
    Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
    Cline SD; Macdonald TL; Osheroff N
    Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance.
    Antony S; Agama KK; Miao ZH; Takagi K; Wright MH; Robles AI; Varticovski L; Nagarajan M; Morrell A; Cushman M; Pommier Y
    Cancer Res; 2007 Nov; 67(21):10397-405. PubMed ID: 17974983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
    Ishida Y; Ohtsu T; Hamada H; Sugimoto Y; Tobinai K; Minato K; Tsuruo T; Shimoyama M
    Jpn J Cancer Res; 1989 Oct; 80(10):1006-13. PubMed ID: 2575608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.